MedPath

A controlled trial of topical Povidone-iodine to treat EKC

Phase 2
Conditions
Epidemic Keratoconjunctivitis.
Superficial keratitis with conjunctivitis
Registration Number
IRCT2015021518004N2
Lead Sponsor
Vice chancellor for research, Zahedan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
60
Inclusion Criteria

Inclusion criteria : Injection ? Purulent discharge ? Foreign body sensation ? Follicular conjunctival reaction ? Pthechia ;?

Exclusion criteria: Pregnancy ? Steroid dependent glaucoma ? Herpes simplex keratitis history ? Symptoms for more than 3 days ? Less than 7 years old ? More than 50 years old ? And lack of follow-up visits? .

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Injection. Timepoint: 1, 4, 7, 10 day. Method of measurement: Ophthalmologist visit.;Discharge. Timepoint: 1, 4, 7, 10 day. Method of measurement: Ophthalmologist visit.;Peri orbital edem. Timepoint: 1, 4, 7, 10 day. Method of measurement: Ophthalmologist visit.;Chemosis. Timepoint: 1, 4, 7, 10 day. Method of measurement: Ophthalmologist visit.;Bloody discharge. Timepoint: 1, 4, 7, 10 day. Method of measurement: Ophthalmologist visit.;Foreign body sensation. Timepoint: 1, 4, 7, 10 day. Method of measurement: Patient answer.;Discharge. Timepoint: 1, 4, 7, 10 day. Method of measurement: Patient answer.;Tearing. Timepoint: 1 ,4, 7, 10 day. Method of measurement: Patient answer.;Feeling cure. Timepoint: 1, 4, 7, 10 day. Method of measurement: Patient answer.;Sub epithelial opacity. Timepoint: 10th day. Method of measurement: Patient answer.
Secondary Outcome Measures
NameTimeMethod
one. Timepoint: none. Method of measurement: none.
© Copyright 2025. All Rights Reserved by MedPath